Exogenous Testosterone (T) Alone or with Finasteride Increases Physical Performance, Grip Strength, and Lean Body Mass in Older Men with Low Serum T
The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Abstract
Testosterone (T) therapy in older men with low serum T levels increases lean body mass and decreases fat mass. These changes might improve physical performance and strength; however, it has not been established whether T therapy improves functional outcome in older men. Moreover, concerns exist about the impact of T therapy on the prostate in older men. The administration of finasteride (F), which partially blocks the conversion of T to the more potent androgen, dihydrotestosterone, attenuates the impact of T replacement on prostate size and prostate-specific antigen. We hypothesized that T replacement in older, hypogonadal men would improve physical function and that the addition of F to this regimen would continue to provide the T-induced improvements in physical performance, strength, and body composition. Seventy men with low serum T (<350 ng/dl), age 65 yr and older, were randomly assigned to receive one of three regimens for 36 months: 1) T enanthate, 200 mg im every 2 wk, with placebo pills daily (T-only); 2) T enanthate, 200 mg every 2 wk, with 5 mg F daily (T + F); or 3) placebo injections and pills (placebo). We obtained serial measurements of timed physical performance, grip strength, lower extremity strength, body composition (by dual-energy x-ray absorptiometry), fasting cholesterol profiles, and hormones. Fifty men completed the 36-month protocol. After 36 months, T therapy significantly improved performance in a timed functional test when compared with baseline and placebo [4.3 +/- 1.6% (mean +/- sem, T-only) and 3.8 +/- 1.0% (T + F) vs. -5.6 +/- 1.9% for placebo (P < 0.002 for both T and T + F vs. placebo)] and increased handgrip strength compared with baseline and placebo (P < 0.05). T therapy increased lean body mass [3.77 +/- 0.55 kg (T-only) and 3.64 +/- 0.56 kg (T + F) vs. -0.21 +/- 0.55 kg for placebo (P < 0.0001)], decreased fat mass, and significantly decreased total cholesterol, low-density lipoprotein, and leptin, without affecting high-density lipoprotein, adiponectin, or fasting insulin levels. These results demonstrate that T therapy in older men with low serum T improves physical performance and strength over 36 months, when administered alone or when combined with F, and suggest that high serum levels of dihydrotestosterone are not essential for these beneficial effects of T in men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elsewhere, testosterone-associated increases in lean mass were accompanied by improvements in handgrip strength, knee extension and leg press and chest press exercises415,416.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [416]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increasing serum testosterone levels to low- to mid-normal ranges through the administration of testosterone for several months in healthy older men resulted in increased muscle strength (133–136) and improved physical performance (134, 135).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [134]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Upon testosterone administration there is a decrease in fat mass and an increase in lean body mass and the net result is often, but not always, that total body weight does not show major changes.”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [17]
In the citing paper
“Most randomized, placebo-controlled trials have indicated that T treatment increases lean mass and reduces fat mass in men with low serum T [2–7]”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [4]
In the citing paper
“but the overall effect on body weight and BMI in men with different T-status is inconsistent.”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [4]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133 · cited 1×
“High levels of adiponectin have been suggested to be cardioprotective (44) and are associated with increased insulin sensitivity (45).”
BackgroundLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Self-citationPlasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Esposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., & Giugliano, D. (2003) · JAMA · doi:10.1001/jama.289.14.1799 · Cited by 1,511
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483 · cited 1×
“In cross-sectional analyses, adiponectin seems to be inversely correlated with FM (40, 41), and levels have been shown to increase with weight loss in normal subjects (42, 43).”
BackgroundYang, W.-S., Lee, W.-J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.-L., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3815 · Cited by 1,181 · cited 1×
“In cross-sectional analyses, adiponectin seems to be inversely correlated with FM (40, 41), and levels have been shown to increase with weight loss in normal subjects (42, 43).”
BackgroundMuscle strength and speed of movement in relation to age and muscle morphology
Larsson, L., Grimby, G., & Karlsson, J. (1979) · Journal of Applied Physiology · doi:10.1152/jappl.1979.46.3.451 · Cited by 1,135
A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women
Frontera, W. R., Hughes, V. A., Lutz, K. J., & Evans, W. J. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.71.2.644 · Cited by 1,011
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“Such changes in body composition are likely due to increases in muscle mass, as has been reported in younger men receiving T (33).”
Result
Cited by
Items 101–200 of 576
The Role of Testosterone in the Elderly: What Do We Know?
Barone, B., Napolitano, L., Abate, M., Cirillo, L., Reccia, P., Passaro, F., Turco, C., Morra, S., Mastrangelo, F., Scarpato, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073535 · Cited by 147
Traish, A. M., Haider, A., Haider, K. S., Doros, G., & Saad, F. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248417691136 · Cited by 130
Testosterone and the Cardiovascular System: A Comprehensive Review of the Basic Science Literature
Herring, M. J., Oskui, P. M., Hale, S. L., & Kloner, R. A. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000271 · Cited by 135
Yeap, B. B., Almeida, O. P., Hyde, Z., Norman, P. E., Chubb, S. A. P., Jamrozik, K., & Flicker, L. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0714 · Cited by 126
Cardiovascular Aspects of Sexual Medicine
Jackson, G., Montorsi, P., Adams, M. A., Anis, T., El-Sakka, A., Miner, M., Vlachopoulos, C., & Kim, E. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01779.x · Cited by 126
Axell, A.-M., MacLean, H. E., Plant, D. R., Harcourt, L. J., Davis, J. A., Jimenez, M., Handelsman, D. J., Lynch, G. S., & Zajac, J. D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00058.2006 · Cited by 125
Burney, B. O., Hayes, T. G., Smiechowska, J., Cardwell, G., Papusha, V., Bhargava, P., Konda, B., Auchus, R. J., & Garcia, J. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2387 · Cited by 120
Testosterone, Sex Hormone–Binding Globulin, and Frailty in Older Men
Mohr, B. A., Bhasin, S., Kupelian, V., Araujo, A. B., O'Donnell, A. B., & McKinlay, J. B. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01121.x · Cited by 117
Isidori, A. M., Balercia, G., Calogero, A. E., Corona, G., Ferlin, A., Francavilla, S., Santi, D., & Maggi, M. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0155-9 · Cited by 118
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men
Snyder, P. J., Ellenberg, S. S., Cunningham, G. R., Matsumoto, A. M., Bhasin, S., Barrett-Connor, E., Gill, T. M., Farrar, J. T., Cella, D., Rosen, R. C., et al. (2014) · Clinical Trials · doi:10.1177/1740774514524032 · Cited by 114
Self-citationIs It Time to Begin a Public Campaign Concerning Frailty and Pre-frailty? A Review Article
Sacha, J., Sacha, M., Soboń, J., Borysiuk, Z., & Feusette, P. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00484 · Cited by 114
“An overall improvement in strength and lean body mass typically appears within 6 months and lasts for the duration of testosterone treatment (Snyder et al., 1999; Wittert et al., 2003; Page et al., 2005).”
BackgroundDHEA enhances effects of weight training on muscle mass and strength in elderly women and men
Villareal, D. T., & Holloszy, J. O. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00100.2006 · Cited by 116
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170009 · Cited by 86
Traish, A. M., Feeley, R. J., & Guay, A. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07305.x · Cited by 110
Sexual Dimorphism in Ischemic Stroke: Lessons from the Laboratory
Manwani, B., & McCullough, L. D. (2011) · Women s Health · doi:10.2217/whe.11.22 · Cited by 120
“Testosterone replacement in deficient men with such comorbidities ameliorates or partially reverses their progression in some clinical trials [165], but similar to the WHI trial, exogenous testosterone administration increased cardiovascular risk and adverse events in men aged 65 years and older.”
BackgroundThe role of hypogonadism in Klinefelter Syndrome
Bojesen, A., Høst, C., Skakkebaek, A. H., & Groth, K. A. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122201 · Cited by 117
Testosterone and ill-health in aging men
Yeap, B. B. (2009) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet1050 · Cited by 119
“1 nmol/l, intramuscular testosterone therapy increased functional physical performance and handgrip strength”
BackgroundWhy Is Androgen Replacement in Males Controversial?
Cunningham, G. R., & Toma, S. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0266 · Cited by 111
Testosterone deficiency in the aging male
McBride, J. A., Carson, C. C., & Coward, R. M. (2016) · Therapeutic Advances in Urology · doi:10.1177/1756287215612961 · Cited by 106
Lunenfeld, B., Saad, F., & Hoesl, C. E. (2005) · The Aging Male · doi:10.1080/13685530500163416 · Cited by 122
“Of note, differences in the incidence of prostate cancer have not been observed among the groups [105].”
BackgroundTestosterone and type 2 diabetes
Grossmann, M., Gianatti, E. J., & Zajac, J. D. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833919cf · Cited by 108
Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition
Bojesen, A., Host, C., & Gravholt, C. H. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq016 · Cited by 103
Behre, H. M., Tammela, T. L. J., Arver, S., Tolrá, J. R., Bonifacio, V., Lamche, M., Kelly, J., Hiemeyer, F., for the European Testogel® Study Team, Giltay, E. J., et al. (2012) · The Aging Male · doi:10.3109/13685538.2012.699562 · Cited by 109
“[14], or in open-label studies [24,25] using parenteral testosterone.”
BackgroundTestosterone and glucose metabolism in men: current concepts and controversies
Grossmann, M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0393 · Cited by 100
“2003, Page et al .”
Eriksson, J., Haring, R., Grarup, N., Vandenput, L., Wallaschofski, H., Lorentzen, E., Hansen, T., Mellström, D., Pedersen, O., Nauck, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176277 · Cited by 101
Pencina, K. M., Travison, T. G., Cunningham, G. R., Lincoff, A. M., Nissen, S. E., Khera, M., Miller, M. G., Flevaris, P., Li, X., Wannemuehler, K. A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad484 · Cited by 107
Age and Sex: Impact on adipose tissue metabolism and inflammation
Varghese, M., Song, J., & Singer, K. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111563 · Cited by 110
Haren, M. T., Siddiqui, A. M., Armbrecht, H. J., Kevorkian, R. T., Kim, M. J., Haas, M. J., Mazza, A., Kumar, V. B., Green, M., Banks, W. A., et al. (2011) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01061.x · Cited by 99
“In older men with low-normal serum testosterone levels, testosterone increases muscle mass (Sih et al., 1997; Snyder et al., 1999; Kenny et al., 2001; Ferrando et al., 2002; Wittert et al., 2003; Page et al., 2005) and strength (Sih et al., 1997; Ferrando et al., 2002; Page et al., 2005).”
BackgroundThe many faces of testosterone
Bain, J. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1417 · Cited by 113
“Treatment of hypogonadal men with testosterone results in improvement in overall physical performance as well as strength as assessed by, eg, hand grip power (Page 2005).”
Chapman, I. M., Visvanathan, R., Hammond, A. J., Morley, J. E., Field, J. B., Tai, K., Belobrajdic, D. P., Chen, R. Y. T., & Horowitz, M. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26538 · Cited by 103
Borst, S. E., Yarrow, J. F., Conover, C. F., Nseyo, U., Meuleman, J. R., Lipinska, J. A., Braith, R. W., Beck, D. T., Martin, J. S., Morrow, M., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00592.2013 · Cited by 98
O'Connell, M. D. L., Roberts, S. A., Srinivas-Shankar, U., Tajar, A., Connolly, M. J., Adams, J. E., Oldham, J. A., & Wu, F. C. W. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1167 · Cited by 98
Reduction in Circulating Testosterone Relates to Exercise Capacity in Men With Chronic Heart Failure
Jankowska, E. A., Filippatos, G. S., Ponikowska, B., Borodulin-Nadzieja, L., Anker, S. D., Banasiak, W., Poole-Wilson, P. A., & Ponikowski, P. P. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.12.011 · Cited by 106
Treatment of Men for “Low Testosterone”: A Systematic Review
Huo, S., Scialli, A. R., McGarvey, S., Hill, E., Tügertimur, B., Hogenmiller, A., Hirsch, A. I., & Fugh-Berman, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162480 · Cited by 97
“4 Page et al, 2005 [81] 48 men age 65–83 (mean 71) with morning serum total T <350 ng/dL (12.1 nM), classified as sedentary ( 60 min/ week of moderate-intensity recreational physical activity); 13 dropouts excluded from analysis T enanthate 200 mg (n = 24) or placebo (n = 24) IM every 2 weeks x 36…”
InfluentialTestosterone replacement therapy: for whom, when and how?
Tsametis, C. P., & Isidori, A. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.007 · Cited by 96
O’Donnell, A. B., Travison, T. G., Harris, S. S., Tenover, J. L., & McKinlay, J. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1227 · Cited by 94
Self-citationTestosterone therapy decreases subcutaneous fat and adiponectin in aging men
Frederiksen, L., Højlund, K., Hougaard, D. M., Mosbech, T. H., Larsen, R., Flyvbjerg, A., Frystyk, J., Brixen, K., & Andersen, M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0565 · Cited by 93
Emerging medication for the treatment of male hypogonadism
Corona, G., Rastrelli, G., Vignozzi, L., & Maggi, M. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.683411 · Cited by 93
“[27] found a significant increase in physical function, in subjects undergoing active treatment (Table 3).”
BackgroundAdverse effects of testosterone replacement therapy: an update on the evidence and controversy
Grech, A., Breck, J., & Heidelbaugh, J. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614548680 · Cited by 91
Effects of Muscle Strength Training and Testosterone in Frail Elderly Males
SULLIVAN, D. H., ROBERSON, P. K., JOHNSON, L. E., BISHARA, O., EVANS, W. J., SMITH, E. S., & PRICE, J. A. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000181840.54860.8b · Cited by 94
“Several recent studies that demonstrated strength improvements with testosterone therapy in healthy older men provided the intervention from 5 to 36 months (7,20).”
BackgroundBody composition, metabolic syndrome and type 2 diabetes in Klinefelter syndrome
Gravholt, C. H., Jensen, A. S., Høst, C., & Bojesen, A. (2011) · Acta Paediatrica · doi:10.1111/j.1651-2227.2011.02233.x · Cited by 86
Diagnosis and treatment of hypogonadism in men
Bhasin, S., & Basaria, S. S. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.12.002 · Cited by 94
Current pharmacotherapies for sarcopenia
Hardee, J. P., & Lynch, G. S. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1622093 · Cited by 84
Male late-onset hypogonadism: pathogenesis, diagnosis and treatment
Huhtaniemi, I., & Forti, G. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.47 · Cited by 88
“Furthermore, only a few studies have reported statistically significant effects on physical function and performance”
BackgroundSainsbury, A., & Zhang, L. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00948.x · Cited by 82
Bhasin, S., Ellenberg, S. S., Storer, T. W., Basaria, S., Pahor, M., Stephens-Shields, A. J., Cauley, J. A., Ensrud, K. E., Farrar, J. T., Cella, D., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30171-2 · Cited by 87
Self-citationSaad, F., Gooren, L., Haider, A., & Yassin, A. (2007) · Archives of Andrology · doi:10.1080/01485010701730880 · Cited by 87
“These parameters were not assessed in this study but the impact of testosterone administration on fat mass and lean body mass has been shown in other studies [Page et al. 2005].”
ResultTestosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment
Gianatti, E., & Grossmann, M. (2019) · Diabetic Medicine · doi:10.1111/dme.13977 · Cited by 91
Legros, J.-J., Meuleman, E. J. H., Elbers, J. M. H., Geurts, T. B. P., Kaspers, M. J. G. H., Bouloux, P. M. G., & _, _. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0634 · Cited by 87
Acute gonadotroph and somatotroph hormonal suppression after traumatic brain injury
Wagner, J., Dusick, J. R., McArthur, D. L., Cohan, P., Wang, C., Swerdloff, R., Boscardin, W. J., & Kelly, D. F. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1092 · Cited by 69
“Testosterone treatment reverses muscle loss (Page et al., 2005; Snyder et al., 1999; Wang et al., 2004).”
Androgen deficiency and atherosclerosis: The lipid link
Traish, A. M., Abdou, R. Y., & Kypreos, K. E. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.09.003 · Cited by 89
Testosterone and the aging male: To treat or not to treat?
Bain, J. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.009 · Cited by 91
“TRT in hypogonadal men improves physical trength as well as performance [7].”
BackgroundMeriggiola, M. C., Armillotta, F., Costantino, A., Altieri, P., Saad, F., Kalhorn, T., Perrone, A. M., Ghi, T., Pelusi, C., & Pelusi, G. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00909.x · Cited by 80
Androgens and estrogens in skeletal sexual dimorphism
Laurent, M. R., Antonio, L., Sinnesael, M., Dubois, V., Gielen, E., Claessens, F., & Vanderschueren, D. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122356 · Cited by 89
Haider, A., Gooren, L. J. G., Padungtod, P., & Saad, F. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1202774 · Cited by 83
Araujo, A. B., Travison, T. G., Bhasin, S., Esche, G. R., Williams, R. E., Clark, R. V., & McKinlay, J. B. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01965.x · Cited by 82
Licea‐Perez, H., Wang, S. C., Szapacs, M. E., & Yang, E. (2008) · Steroids · doi:10.1016/j.steroids.2008.01.018 · Cited by 83
Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone
Yassin, A. A., Saad, F., & Gooren, L. J. (2008) · Andrologia · doi:10.1111/j.1439-0272.2008.00851.x · Cited by 84
“In a study by Page et al. (2005), testosterone administration improved body composition (reduction in trunk fat, increase in lean body mass, improvement of plasma triglycerides, total cholesterol and LDL, no impairment of HDL).”
BackgroundGarekani, E. T., Mohebbi, H., Kraemer, R. R., & Fathi, R. (2011) · Peptides · doi:10.1016/j.peptides.2011.01.027 · Cited by 77
Skinner, J. W., Otzel, D. M., Bowser, A., Nargi, D., Agarwal, S., Peterson, M. D., Zou, B., Borst, S. E., & Yarrow, J. F. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12291 · Cited by 76
The Clinical Care of Frail, Older Adults
Ko, F. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.08.007 · Cited by 85
Are we closer to having drugs to treat muscle wasting disease?
Morley, J. E., von Haehling, S., & Anker, S. D. (2014) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-014-0149-7 · Cited by 72
Androgen effects on skeletal muscle: implications for the development and management of frailty
Wu, F., & O’Connell, M. D. L. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122581 · Cited by 77
Cachexia and aging: An update based on the fourth international cachexia meeting
Morley, J. E., Anker, S. D., & Evans, W. J. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0009-x · Cited by 74
“Testosterone has been shown to enhance functional status in older persons (175) and also in persons with congestive heart failure (176).”
Weight Loss in the Nursing Home
Morley, J. E. (2007) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2007.02.003 · Cited by 78
Sarcopenia: An Endocrine Disorder?
McKee, A. M., Morley, J. E., Matsumoto, A. M., & Vinik, A. I. (2017) · Endocrine Practice · doi:10.4158/ep171795.ra · Cited by 80
Self-citationBurnett‐Bowie, S. M., Roupenian, K. C., Dere, M. E., Lee, H., & Leder, B. Z. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03327.x · Cited by 73
Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
Mohammadi‐Shemirani, P., Chong, M., Pigeyre, M., Morton, R. W., Gerstein, H. C., & Paré, G. (2020) · eLife · doi:10.7554/elife.58914 · Cited by 73
Yarrow, J. F., McCoy, S. C., & Borst, S. E. (2010) · Steroids · doi:10.1016/j.steroids.2010.01.019 · Cited by 80
Body composition, metabolic syndrome and testosterone in ageing men
Allan, C. A., Strauss, B. J. G., & McLachlan, R. I. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901552 · Cited by 67
Yang, E. J., Lim, S. K., Lim, J., Kim, K. W., Jang, H. C., & Paik, N. (2011) · Metabolism · doi:10.1016/j.metabol.2011.07.005 · Cited by 72
Anabolic-Androgenic Steroid Use in Sports, Health, and Society
BHASIN, S., HATFIELD, D. L., HOFFMAN, J. R., KRAEMER, W. J., LABOTZ, M., PHILLIPS, S. M., & RATAMESS, N. A. (2021) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002670 · Cited by 54
The complex association between metabolic syndrome and male hypogonadism
Dimopoulou, C., Goulis, D. G., Corona, G., & Maggi, M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.024 · Cited by 70
Dias, J. P., Melvin, D., Simonsick, E. M., Carlson, O., Shardell, M. D., Ferrucci, L., Chia, C. W., Basaria, S., & Egan, J. M. (2016) · Andrology · doi:10.1111/andr.12126 · Cited by 65
“Other studies in elderly men have demonstrated that T treatment improves hand grip strength (Sih et al., 1997; Page et al., 2005).”
ResultTestosterone replacement in prostate cancer survivors with hypogonadal symptoms
Leibowitz, R. L., Dorff, T. B., Tucker, S. J., Symanowski, J. T., & Vogelzang, N. J. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08980.x · Cited by 65
Handgrip Strength and Socially Dominant Behavior in Male Adolescents
Gallup, A. C., O'Brien, D. T., White, D. D., & Wilson, D. S. (2010) · Evolutionary Psychology · doi:10.1177/147470491000800207 · Cited by 73
Neto, W. K., Gama, E. F., Rocha, L. Y., Ramos, C. C., Taets, W., Scapini, K. B., Ferreira, J. B., Rodrigues, B., & Caperuto, É. (2015) · AGE · doi:10.1007/s11357-014-9742-0 · Cited by 64
“The drug used was testosterone enanthate (SheffieldMoore et al. 2011; Page et al. 2005; Ferrando et al. 2003; Blackman et al. 2002), oxandrolone (Schroeder et al.”
BackgroundBorst, S. E., & Yarrow, J. F. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00111.2015 · Cited by 62
Kovacic, P., & Pozos, R. S. (2006) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20083 · Cited by 67
Parahiba, S. M., Ribeiro, É. C. T., Corrêa, C., Bieger, P., Perry, I. D. S., & Souza, G. C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111106 · Cited by 64
Cinar, V., Polat, Y., Baltaci, A. K., & Mogulkoc, R. (2011) · Biological Trace Element Research · doi:10.1007/s12011-010-8676-3 · Cited by 62
“Testosterone supplementation increased physical performance and strain by reducing fat density and increasing the amount of muscle [22].”
BackgroundMuscle Wasting in Ageing and Chronic Illness
Ebner, N., Sliziuk, V., Scherbakov, N., & Sandek, A. (2015) · ESC Heart Failure · doi:10.1002/ehf2.12033 · Cited by 61
Digit ratio (2D:4D) and handgrip strength in subjects of Han ethnicity: Impact of sex and age
Zhao, D., Li, B., Yu, K., & Lianbin, Z. (2012) · American Journal of Physical Anthropology · doi:10.1002/ajpa.22130 · Cited by 63
Handgrip Strength as a Darwinian Fitness Indicator in Men
Gallup, A. C., & Fink, B. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.00439 · Cited by 62
“…between the sexes in terms of stature and overall body mass (Isen et al., 2014), and thus likely reflects the disproportionately higher levels of androgenic hormones (Page et al., 2005) and upper-body muscularity of men compared to women (Kallman et al., 1990; Lassek and Gaulin, 2009).”
BackgroundBeggs, L. A., Yarrow, J. F., Conover, C. F., Meuleman, J. R., Beck, D. T., Morrow, M., Zou, B., Shuster, J. J., & Borst, S. E. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00184.2014 · Cited by 61
Male Hypogonadism: An Update on Diagnosis and Treatment
Darby, E. L., & Anawalt, B. D. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504050-00003 · Cited by 69
Self-citationLate-Life Onset Hypogonadism: A Review
Bassil, N., & Morley, J. E. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.02.003 · Cited by 59
“Testosterone administration improves body composition with a decrease of fat mass and an increase of lean body mass.(96,97) In most of these studies, the body weight change did not differ”
Sattler, F., Bhasin, S., He, J., Chou, C.-P., Castaneda-Sceppa, C., Yarasheski, K., Binder, E., Schroeder, E. T., Kawakubo, M., Zhang, A., et al. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq183 · Cited by 57
Pharmacological Treatment of Geriatric Cachexia: Evidence and Safety in Perspective
Yeh, S., Lovitt, S., & Schuster, M. W. (2007) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2007.05.001 · Cited by 59
Discovery of Potent and Muscle Selective Androgen Receptor Modulators through Scaffold Modifications
Li, J. J., Sutton, J. C., Nirschl, A. A., Zou, Y., Wang, H., Sun, C., Pi, Z., Johnson, R., Stanley R. Krystek, Seethala, R., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070312d · Cited by 62
Erectile dysfunction, physical activity and physical exercise: Recommendations for clinical practice
Duca, Y., Calogero, A. E., Cannarella, R., Giacone, F., Mongioì, L. M., Condorelli, R. A., & Vignera, S. L. (2019) · Andrologia · doi:10.1111/and.13264 · Cited by 62
Knapp, P. E., Storer, T. W., Herbst, K. L., Singh, A. B., Dzekov, C., Dzekov, J., LaValley, M., Zhang, A., Ulloor, J., & Bhasin, S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90213.2008 · Cited by 56
Voice and Handgrip Strength Predict Reproductive Success in a Group of Indigenous African Females
Atkinson, J., Pipitone, R. N., Sorokowska, A., Sorokowski, P., Mberira, M., Bartels, A., & Gallup, G. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041811 · Cited by 61
“, prenatal) effects of testosterone [28], as well as activational effects of testosterone in elderly [29], normal [30] and hypogonadal/low serum testosterone men [31– 34].”
BackgroundGonadal Steroids and Body Composition, Strength, and Sexual Function in Men
Finkelstein, J. S., Yu, E. W.-Y., & Burnett-Bowie, S.-A. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1313169 · Cited by 63
Muscular Dystrophies at Different Ages: Metabolic and Endocrine Alterations
Cruz‐Guzmán, O. D. R., García, A. L. C., & Rodríguez‐Cruz, M. (2012) · International Journal of Endocrinology · doi:10.1155/2012/485376 · Cited by 53
“The importance of testosterone in the maintenance of muscle mass is critical, and testosterone therapy should be considered when hypogonadism is present [43, 44].”
BackgroundDo low testosterone levels contribute to ill-health during male ageing?
Yeap, B. B., de Araújo, A. B., & Wittert, G. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.725461 · Cited by 53
GUO, C., GU, W., LIU, M., PENG, B., YAO, X., YANG, B., & ZHENG, J. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2957 · Cited by 51
The Current Understanding of Sarcopenia: Emerging Tools and Interventional Possibilities
Delmonico, M. J., & Beck, D. T. (2016) · American Journal of Lifestyle Medicine · doi:10.1177/1559827615594343 · Cited by 61
Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.
Cattabiani, C., Basaria, S. S., Ceda, G. P., Luci, M., Vignali, A., Lauretani, F., Valenti, G., Volpi, R., & Maggio, M. G. (2012) · PubMed · doi:10.3275/8061 · Cited by 58
“This double effect is evident in long duration surveys, such as those of Page (41), Snyder (37) at 36 months, Nair (43) at 24 months, Wittert (42) and Dean (45) at 12 months.”
BackgroundResultInfluentialTraish, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_22 · Cited by 58
Metadata
- Authors
- Page, S. T., Amory, J. K., Bowman, F. D., Anawalt, B. D., Matsumoto, A. M., Bremner, W. J., & Tenover, J. L.
- Affiliations
- Emory University (US)
- VA Puget Sound Health Care System (US)
- University of Washington (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-03
- Volume
- 90
- Issue
- 3
- Pages
- 1502-1510
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2116827517
- Cited by
- 566
- References
- 49
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 10 · 2023: 14 · 2022: 20 · 2021: 12 · 2020: 16 · 2019: 26 · 2018: 30 · 2017: 31 · 2016: 29 · 2015: 22 · 2014: 34 · 2013: 24 · 2012: 34
- FWCI
- 25.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ResearchWorks at the University of Washington (University of Washington) (submittedVersion)
- Funders
- National Institutes of Health (5r01ag010975-04, HL007028)
- National Institute on Aging (K23AG027238, AG10975)
- National Heart, Lung, and Blood Institute (HL-007028, T32HL007028)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone replacement therapy, finasteride, hypogonadism, older men, physical performance, grip strength, lean body mass, body composition, testosterone enanthate, prostate-specific antigen, cholesterol, leptin, functional performance, lower limb strength
- MeSH terms
- Aged, Aged, 80 and over, Aging, Androgens, Body Composition, Double-Blind Method, Drug Therapy, Combination, Enzyme Inhibitors, Humans, Hypogonadism, Insulin, Lipids, Male, Motor Activity, Testosterone, Body Mass Index, Finasteride, Hand Strength, Leptin, Intercellular Signaling Peptides and Proteins, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.